Recruiting
Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors
This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.
ClinicalTrials.gov IDNCT07350694
PhaseNA
Enrollment250
SponsorHealthNet Transcultural Psychosocial Organization
Age20 Years
SexALL
Conditions studied
Diabetes Type 2, Type II Diabetes Mellitus
About this study
This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.
Interventions
- Behavioral: PLA — An PLA based intervention would be carried out to prepare the individuals with TIIDM. The intervention would be carried out for a tentative time of 2 to 3 hours to educate the community. The study participants would be evaluated after completion of 10 months of the intervention. A structured, validated and literature-based end line assessment checklist will be devised to assess the feasibility of the intervention.
Primary outcomes
- To culturally adapt PLA-based intervention (D-Magic) for primary prevention and control of TIIDM in rural communities of Afghanistan (10 months)
- To test the feasibility of the culturally adapted PLA-based intervention (D-Magic) (12 months)
- To test the acceptability of the culturally adapted PLA-based intervention (D-Magic) (12 months)
Eligibility information
Inclusion Criteria:
* For intervention phase: Individuals aged 20 years and above. For baseline and endline assessments (before and after the intervention): Individuals aged 30 years and above.
* Participants residing in the randomized clusters of Kabul, Afghanistan Individuals willing to participate in the study and provide consent.
* All individuals with normoglycemia, intermediate hyperglycaemia, and diabetes are encouraged to participate.
* Participants who can attend the scheduled meetings and interventions as per the study protocol.
Exclusion Criteria:
* For Intervention phase: Individuals below the age of 20 years. For baseline and endline assessments (before and after the intervention): individuals below the age of 30 years.
* Individuals unwilling to provide consent for participation.
* Participants with reported health conditions that may hinder their active involvement in the study.
* Individuals with non-compliance with research protocols
Study locations
- HealthNet TPO, Afghanistan, Kabul, Kabul 24000 Afghanistan
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.